An miR−122−5p mimic enhanced renal fibrosis with the increased expression of TGFR2, whereas an miR−122−5p inhibitor suppressed renal fibrosis with the increased expression of FOXO3 (with the upregulation of the downstream genes, LC3). The gene discussed is TGFBR2; the disease is renal fibrosis.